HHS Clears the Way for Use of New COVID-19 Tests without FDA Emergency Use Authorization by Glenn S. Demby | Aug 29, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings by Glenn S. Demby | Aug 20, 2020 | Articles, Essential, FDA-lir, Laboratory Industry Report, LDTs-lir... This content is for Paid Members only.RegisterAlready a member? Log in here
Battle of the SARS-CoV-2 Antibody Immunoassays: Only One Test Meets Both UK Sensitivity and Specificity Targets by Glenn S. Demby | Aug 12, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Cracks Down on Improper Marketing of SARS-CoV-2 Antibody Tests by Glenn S. Demby | Aug 7, 2020 | Articles, Clinical Diagnostics Insider, FDA-dtet, Lab Compliance Advisor... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Cracks Down on Improper Marketing of SARS-CoV-2 Antibody Tests by Glenn S. Demby | Aug 4, 2020 | Articles, Clinical Diagnostics Insider, FDA-lca, G2 Insider-dtet, Lab Compliance Advisor... This content is for Paid Members only.RegisterAlready a member? Log in here